Provital GmbH has been acquired by EMERAM Capital Partners
Dr. Thomas Brandner has sold a majority stake in Provital GmbH to private equity firm EMERAM Capital Partners. The transaction secures the future development and growth opportunities of the pet food company as EMERAM Capital Partners takes on ownership and acts as its strategic partner.
The Provital Group, consisting of Provital GmbH and TN Logistik GmbH, based in Taufkirchen, is Germany’s leading provider of premium pet food in a direct-to-consumer sales system. Provital GmbH specializes in natural, high-quality dog and cat food under the established brand Anifit, whose products are specifically tailored to the needs of quality-conscious pet owners. Over 2,000 expert advisors offer professional and targeted advice and maintain close customer relationships.
EMERAM Capital Partners is an independent investment firm for mid-sized companies based in the German-speaking region. Its sector focus includes technology and software, value-added services and non-discretionary consumers. Since it was founded in 2012, the company has continuously grown and currently has more than 20 employees.
As an experienced M&A advisory firm in the pets sector, Oaklins’ team in Germany provided comprehensive support to Provital GmbH’s shareholder, Dr. Thomas Brandner, in the search for a new majority shareholder as part of his entrepreneurial succession.
Dr. Thomas Brandner
Shareholder, Provital GmbH
Talk to the deal team
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Learn more